Literature DB >> 12056961

Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor.

Daniel Creamer1, Michael Allen, Rhys Jaggar, Richard Stevens, Roy Bicknell, Jonathan Barker.   

Abstract

BACKGROUND: Severe forms of psoriasis can be complicated by systemic microvascular hyperpermeability. Vascular endothelial growth factor (VEGF) possesses potent vascular permeability activity. We suggest that VEGF enters the systemic circulation and acts on microvessels to mediate hyperpermeability.
OBJECTIVES: To quantify renal microvascular permeability and circulating VEGF concentration in severe psoriasis, and to investigate the relationship between plasma VEGF concentration and skin and joint involvement.
DESIGN: Inception cohort studies of patients with generalized pustular psoriasis and plaque psoriasis.
SETTING: St John's Institute of Dermatology, London, England. PATIENTS: Twenty-two patients (15 men and 7 women) with moderate and severe psoriasis were recruited (age range, 29-77 years; mean age, 47 years); 5 had generalized pustular psoriasis, 2 had erythrodermic psoriasis, and 15 had moderate-severe plaque psoriasis. An age- and sex-matched control group of 17 individuals (10 men and 7 women) was recruited (age range, 29-69 years; mean age, 42 years).
RESULTS: There was pathological proteinuria in patients with relapsing generalized pustular psoriasis, (4-fold increase in urinary protein excretion rate in relapse compared with remission). In patients with moderate and severe psoriasis, mean plasma VEGF concentration during relapse was approximately 2.5 times greater than during remission (mean VEGF(relapse) = 257 pg/mL; mean VEGF(remission) = 103 pg/mL; P<.01). There was a correlation between extent of skin involvement and plasma VEGF level (mean VEGF(severe psoriasis) = 365 pg/mL; mean VEGF(moderate psoriasis) = 149 pg/mL; P =.03). There was a correlation between presence of psoriatic arthritis and plasma VEGF level (mean relapse VEGF(arthritis) = 277 pg/mL; mean relapse VEGF(nonarthritis) = 103.5 pg/mL; P =.03).
CONCLUSIONS: Generalized pustular psoriasis is accompanied by pathological proteinuria and elevated plasma VEGF levels. Plasma VEGF concentration is significantly elevated in patients with extensive skin and joint involvement and may act on renal microvasculature to induce hyperpermeability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12056961     DOI: 10.1001/archderm.138.6.791

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  17 in total

Review 1.  Update on the natural history and systemic treatment of psoriasis.

Authors:  Stephen K Richardson; Joel M Gelfand
Journal:  Adv Dermatol       Date:  2008

2.  Serum vascular endothelial growth factor, transforming growth factor β1, and nitric oxide levels in patients with psoriasis vulgaris: their correlation to disease severity.

Authors:  Abdel-Raheim M A Meki; Hani Al-Shobaili
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 3.  Psoriasis: advances in pathophysiology and management.

Authors:  A MacDonald; A D Burden
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

Review 4.  [Therapeutic strategies for psoriasis and psoriatic arthritis].

Authors:  G Wozel
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

5.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

6.  Substance P (SP) induces expression of functional corticotropin-releasing hormone receptor-1 (CRHR-1) in human mast cells.

Authors:  Shahrzad Asadi; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Alexandra Miniati; Nikolaos Sismanopoulos; Magdalini Vasiadi; Bodi Zhang; Dimitrios Kalogeromitros; Theoharis C Theoharides
Journal:  J Invest Dermatol       Date:  2011-11-17       Impact factor: 8.551

7.  IL-9 induces VEGF secretion from human mast cells and IL-9/IL-9 receptor genes are overexpressed in atopic dermatitis.

Authors:  Nikolaos Sismanopoulos; Danae A Delivanis; Konstantinos D Alysandratos; Asimenia Angelidou; Magdalini Vasiadi; Anastasia Therianou; Theoharis C Theoharides
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

Review 8.  The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients.

Authors:  Ulrich Mrowietz; James T Elder; Jonathan Barker
Journal:  Arch Dermatol Res       Date:  2006-10-05       Impact factor: 3.017

9.  Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.

Authors:  Amber Y Goedkoop; Maarten C Kraan; Daisy I Picavet; Menno A de Rie; Marcel B M Teunissen; Jan D Bos; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2004-05-26       Impact factor: 5.156

Review 10.  Vascular endothelial growth factor (VEGF) in autoimmune diseases.

Authors:  Jozélio Freire Carvalho; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2007-03-06       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.